Empowering the Full Value Chain, Building a CDMO Industry Benchmark

As an innovation-driven, industry-leading CDMO company, JiuZhou Pharmaceutical leverages an internationally standardized quality control system, EHS management system, and excellent operational capabilities. Combining technological innovation advantages with scalable production capacity, the company provides one-stop pharmaceutical custom R&D and manufacturing (CDMO) services for global pharmaceutical companies, biotech firms, and research institutions. These services cover small molecule chemical drugs, peptide drugs, antibody-drug conjugates, and small nucleic acid drugs. The service projects span across therapeutic areas such as oncology, heart failure, antiviral, central nervous system, and cardiovascular diseases. With extensive experience in serving top-tier clients and continuously upgraded production capacities, the company achieves seamless integration from laboratory R&D to commercial-scale production. Through a precise and efficient service model, JiuZhou Pharmaceutical injects strong momentum into global pharmaceutical innovation.

Technology Transformation, Building an Innovative Technology Matrix

Over the years, JiuZhou Pharmaceutical has continuously deepened its dual-focus strategy on client pipelines and product pipelines, achieving high-quality growth in both commercial and innovative projects. The project matrix has become increasingly diverse and comprehensive. In the field of technological R&D, the company relies on its long-standing experience in new drug development to make significant breakthroughs in green manufacturing technology innovations and applications. It has established industry-leading technology platforms such as chiral catalysis, continuous processes, fluorochemistry, enzyme catalysis, photocatalysis, electrochemistry, crystallization processes, peptide conjugation, and formulation research. Through numerous project practices and technology transfer cases, the company efficiently tackles process challenges and technical hurdles for domestic and international clients, offering innovative solutions with benchmark significance for the industry.

Mission-Driven, Anchoring the Future of Global Pharmaceutical Innovation

"Care for life, safeguard health" is the mission that JiuZhou Pharmaceutical has always adhered to. In the future, the company will continue to use technological innovation as the core driving force, deepen its international strategic layout, and expand its service network in core markets such as Europe, America, and Asia-Pacific. It is committed to building a globally leading CDMO one-stop service brand, promoting the commercialization of innovative drugs, and bringing more hope for life to patients worldwide.

Empowering the Full Value Chain, Building a CDMO Industry Benchmark

As an innovation-driven, industry-leading CDMO company, JiuZhou Pharmaceutical leverages an internationally standardized quality control system, EHS management system, and excellent operational capabilities. Combining technological innovation advantages with scalable production capacity, the company provides one-stop pharmaceutical custom R&D and manufacturing (CDMO) services for global pharmaceutical companies, biotech firms, and research institutions. These services cover small molecule chemical drugs, peptide drugs, antibody-drug conjugates, and small nucleic acid drugs. The service projects span across therapeutic areas such as oncology, heart failure, antiviral, central nervous system, and cardiovascular diseases. With extensive experience in serving top-tier clients and continuously upgraded production capacities, the company achieves seamless integration from laboratory R&D to commercial-scale production. Through a precise and efficient service model, JiuZhou Pharmaceutical injects strong momentum into global pharmaceutical innovation.

Technology Transformation, Building an Innovative Technology Matrix

Over the years, JiuZhou Pharmaceutical has continuously deepened its dual-focus strategy on client pipelines and product pipelines, achieving high-quality growth in both commercial and innovative projects. The project matrix has become increasingly diverse and comprehensive. In the field of technological R&D, the company relies on its long-standing experience in new drug development to make significant breakthroughs in green manufacturing technology innovations and applications. It has established industry-leading technology platforms such as chiral catalysis, continuous processes, fluorochemistry, enzyme catalysis, photocatalysis, electrochemistry, crystallization processes, peptide conjugation, and formulation research. Through numerous project practices and technology transfer cases, the company efficiently tackles process challenges and technical hurdles for domestic and international clients, offering innovative solutions with benchmark significance for the industry.

Mission-Driven, Anchoring the Future of Global Pharmaceutical Innovation

"Care for life, safeguard health" is the mission that JiuZhou Pharmaceutical has always adhered to. In the future, the company will continue to use technological innovation as the core driving force, deepen its international strategic layout, and expand its service network in core markets such as Europe, America, and Asia-Pacific. It is committed to building a globally leading CDMO one-stop service brand, promoting the commercialization of innovative drugs, and bringing more hope for life to patients worldwide.

Empowering the Full Value Chain, Building a CDMO Industry Benchmark

As an innovation-driven, industry-leading CDMO company, JiuZhou Pharmaceutical leverages an internationally standardized quality control system, EHS management system, and excellent operational capabilities. Combining technological innovation advantages with scalable production capacity, the company provides one-stop pharmaceutical custom R&D and manufacturing (CDMO) services for global pharmaceutical companies, biotech firms, and research institutions. These services cover small molecule chemical drugs, peptide drugs, antibody-drug conjugates, and small nucleic acid drugs. The service projects span across therapeutic areas such as oncology, heart failure, antiviral, central nervous system, and cardiovascular diseases. With extensive experience in serving top-tier clients and continuously upgraded production capacities, the company achieves seamless integration from laboratory R&D to commercial-scale production. Through a precise and efficient service model, JiuZhou Pharmaceutical injects strong momentum into global pharmaceutical innovation.

Technology Transformation, Building an Innovative Technology Matrix

Over the years, JiuZhou Pharmaceutical has continuously deepened its dual-focus strategy on client pipelines and product pipelines, achieving high-quality growth in both commercial and innovative projects. The project matrix has become increasingly diverse and comprehensive. In the field of technological R&D, the company relies on its long-standing experience in new drug development to make significant breakthroughs in green manufacturing technology innovations and applications. It has established industry-leading technology platforms such as chiral catalysis, continuous processes, fluorochemistry, enzyme catalysis, photocatalysis, electrochemistry, crystallization processes, peptide conjugation, and formulation research. Through numerous project practices and technology transfer cases, the company efficiently tackles process challenges and technical hurdles for domestic and international clients, offering innovative solutions with benchmark significance for the industry.

Mission-Driven, Anchoring the Future of Global Pharmaceutical Innovation

"Care for life, safeguard health" is the mission that JiuZhou Pharmaceutical has always adhered to. In the future, the company will continue to use technological innovation as the core driving force, deepen its international strategic layout, and expand its service network in core markets such as Europe, America, and Asia-Pacific. It is committed to building a globally leading CDMO one-stop service brand, promoting the commercialization of innovative drugs, and bringing more hope for life to patients worldwide.